logo
Medical news
of the North Caucasus
Scientific journal
Mass media registration certificate dated December 7, 2006.
Series ПИ #ФС 77-26521.
Federal service for surveillance over non-violation of the legislation in the sphere of mass communications and protection of cultural heritage.
ISSN 2073-8137
rus
русский
eng
english

Site search


Correspondence address
310 Mira Street, Stavropol, Russia, 355017

Tel
+7 865 2352511, +7 865 2353229.

E-mail
medvestnik@stgmu.ru

Epiphysis in pediatric patients: the role of epiphyseal melatonin in the genesis of autism

[Reviews]
Eduard Arushanyan;

Download

References:
1. Arushanyan E. B. Uspekhi fiziol. nauk. 1991;22:122–141.
2. Arushanyan E. B. Meditsinskii Vestnik Sevrnogo Kavkaza. – Medical News of North Caucasus. 2009;4:66–75.
3. Arushanyan E. B. Zhurn. vyssh. nervn. deyat. 2011;61:45–659.
4. Arushanyan E. B. Eksper. i klin. farmakol. 2012;75:35–40.
5. Arushanyan E. B. Meditsinskii Vestnik Sevrnogo Kavkaza. – Medical News of North Caucasus. 2012;8(1):116–122.
6. Isayev D. N. Psikhopatologiya detskogo vozrasta. 2007;425.
7. Anatnostou E., Hansen R., Kaczmarska J., McGrew S.D. Curr Opin Pediatr. 2011;23:621–627.
8. Andersen I. M., Kaczmarska J., McGrew S.D. Child Neurol. 2006;23:482–485.
9. Bourgeron T. Cold Spring Harb Symp Quant Biol. 2007;72:645–654.
10. Chaste P., Clement N., Mercadi O. PloS One. 2010;15:11495.
11. Chevreuil C.,Polard E., Gisquel G. Therapie. 2010;65:1–12.
12. Cortesi F., Giannotti F., Sebastiani T. Controlled release melatonin, singly and combined with cognitive behavioral therapy, for persistent insomnia in children with autism spectrum disorders: a randomized placebo-controlled trial. J. Sleep Res. 2012;175:252–261.
13. Doyen C., Mighiu D., Kaye K. et al. Eur. Child. Adolesc. Psychiatry. 2011;20:231–239.
14. Giannotti F., Cortesi F., Cerquiglini A. J. Autism Dev. Disord. 2006;36:741–752.
15. Golnik A. E., Ireland M. J. Autism Dev. Disord. 2009;39:996–1005.
16. Jan, J. E., O’Donnell M.E. J. Pineal Res. 1996;21:193–199.
17. Jonsson J., Lingggren E., Bremer A. BMC Med. Genomics. 2010;3:10.
18. Kalsbeek A., Perrau-Lenz S., Buijs E. S. Chronobiol Int. 2006;23:521–535.
19. Kulman G., Lissoni P., Povelli F. Neuro-Endocrinol. Lett. 2000;21:31–34.
20. Leu P.M., Beydeman L., Botzolakis E.J. J. Autism Dev. Disord. 2011;41:427–433.
21. Malow B., Adkins K.W., McGrew S.G. J. Autism Dev. Disord. 2011;41:135–141.
22. Maski K.P., Jeste S.S., Spence S. J. Curr Opin Pediatr. 2011;23:609–615.
23. Melke J., Goubran Botros H., Chaste P. Mol Psychiatry. 2008;13:90–98.
24. Miano S., Ferri R. Paediatr Drugs. 2010;12:75–84.
25. Nir I., Meir D., Ziber N. J. Autism Dev Disord. 1995;25:641–654.
26. Pandi-Perumal S.R., Srinivasan V., Spence D.W. CNS Drugs. 2007;26:995–1018.
27. Parr J. Autism. Clin Evid. 2010;7:322–326.
28. Tordjman S., Anderson G. M., Pichard N. Biol. Psychiatry. 2005;57:134–138.
29. Wasdell M. B., Jan J.E., Bomben M. J. Pineal Res. 2008; 44:57–64.
30. Wright B., Sims D., Smart S. J. Autism Dev Disord. 2011;41:175– 184.


Founders:
Stavropol State Medical Academy
Pyatigorsk State Research Institute of Balneotherapeutics
Pyatigorsk State Pharmaceutical Academy